MMMMMMMMMMMMMMMMmmmmmmmm
I think potency assay data has proven sufficient but there is still outstanding issues to resolve. Why weren't they resolved as per CRL advice?
"seeking to address all remaining product characterization issues" - no slam dunk here as yet
Still - beats a no
Reg
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-31
-
- There are more pages in this discussion • 1,062 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |